Clinical Trials Directory

Trials / Completed

CompletedNCT00712907

Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
Male
Age
19 Years – 35 Years
Healthy volunteers
Accepted

Summary

High arterial blood oxygen tension leads to vasoconstriction of retinal vessels, possibly related to an interaction between reactive oxygen species and endothelium-derived vasoactive factors. Vitamin C is a potent antioxidant capable of reversing endothelial dysfunction due to increased oxidant stress. Vitamin C appears to have vasodilatory properties, but the underlying mechanisms are not well understood. In the present study we hypothesized that hyperoxic vasoconstriction of retinal vessels could be diminished by vitamin C. Ocular blood flow will be determined by non-invasive methods, including laser Doppler velocimetry and the Zeiss retinal vessel analyser.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTvitamin C (Mayrhofer) 24mg/min i.v. for 64 minSubstance: Ascorbic acid (Mayrhofer) Manufacturer: Mayrhofer, Linz, Austria Dosage form: i.v. Dosage: 24mg/min over 64 min Dosage reference: Ting HH 1996
DIETARY_SUPPLEMENTPlaceboSubstance: Physiologic saline solution 0.9% (placebo) Dosage form: i.v. Dosage: 24ml/min over 64 min
OTHER100% O2 (AGA) two times for 12 minSubstance: 100% oxygen (AGA, Vienna, Austria, gases for human use) Manufacturer: AGA, Vienna, Austria, gases for human use Dosage form: Inhalation through an oxygenmask over a period of 12 minutes two times per study day. Dosage reference: Strenn K 1997

Timeline

Start date
2003-02-01
Primary completion
2003-05-01
Completion
2003-05-01
First posted
2008-07-10
Last updated
2008-07-10

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00712907. Inclusion in this directory is not an endorsement.